Viewing Study NCT00003894

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-02 @ 3:03 PM
Study NCT ID: NCT00003894
Status: COMPLETED
Last Update Posted: 2011-03-07
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant
Sponsor: Roswell Park Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft Versus Host Disease View
None Unspecified Adult Solid Tumor, Protocol Specific View
None Unspecified Childhood Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None unspecified childhood solid tumor, protocol specific View
None unspecified adult solid tumor, protocol specific View
None graft versus host disease View